Related references
Note: Only part of the references are listed.Synthesis and evaluation of biological activity of 1-[2-amino-4-methylthiazol-5-yl]-3-arylpropenones
A. V. Lozynskyi et al.
Biopolymers and Cell (2022)
Identification of different side effects between PARP inhibitors and their polypharmacological multi-target rationale
Daranjit Sandhu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Potential synthetic lethality for breast cancer: A selective sirtuin 2 inhibitor combined with a multiple kinase inhibitor sorafenib
Hua-Li Wang et al.
PHARMACOLOGICAL RESEARCH (2022)
Novel hybrid pyrrolidinedione-thiazolidinones as potential anticancer agents: Synthesis and biological evaluation
Nataliya Finiuk et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Synthesis of novel indole-thiazolidinone hybrid structures as promising scaffold with anticancer potential
Anna Kryshchyshyn-Dylevych et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1
Kevin Ryan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
An Open Access Database of Licensed Cancer Drugs
Pan Pantziarka et al.
FRONTIERS IN PHARMACOLOGY (2021)
Fluzoparib increases radiation sensitivity of non-small cell lung cancer (NSCLC) cells without BRCA1/2 mutation, a novel PARP1 inhibitor undergoing clinical trials
Jing Luo et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Structural basis for allosteric PARP-1 retention on DNA breaks
Levani Zandarashvili et al.
SCIENCE (2020)
Exploration of certain 1,3-oxazole-and 1,3-thiazole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents
Duong Tien Anh et al.
BIOORGANIC CHEMISTRY (2020)
Design, synthesis, and biological evaluation of chalcone-linked thiazole-imidazopyridine derivatives as anticancer agents
Vellanki Ragha Suma et al.
MEDICINAL CHEMISTRY RESEARCH (2020)
Evaluation of the Anticancer Activities of Novel Transition Metal Complexes with Berenil and Nitroimidazole
Robert Czarnomysy et al.
MOLECULES (2020)
Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
Win Topatana et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Design, Synthesis, and Molecular Docking of Paracyclophanyl-Thiazole Hybrids as Novel CDK1 Inhibitors and Apoptosis Inducing Anti-Melanoma Agents
Ashraf A. Aly et al.
MOLECULES (2020)
Design, computational studies, synthesis and biological evaluation of thiazole-based molecules as anticancer agents
Anuradha et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
A thiazole-derived oridonin analogue exhibits antitumor activity by directly and allosterically inhibiting STAT3
Xiaofei Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Synthesis, anticancer activity and mechanism of action of new thiazole derivatives
Temistocles Italo de Santana et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Targeting Phosphopeptide Recognition by the Human BRCA1 Tandem BRCT Domain to Interrupt BRCA1-Dependent Signaling
Jayaprakash Periasamy et al.
CELL CHEMICAL BIOLOGY (2018)
Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors
Navriti Chadha et al.
MOLECULAR DIVERSITY (2017)
Design and discovery of novel thiazole derivatives as potential MMP inhibitors to protect against acute lung injury in sepsis rats via attenuation of inflammation and apoptotic oxidative stress
Lingqing Ge et al.
RSC ADVANCES (2017)
A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells
Zhor Senhaji Mouhri et al.
BMC CANCER (2017)
Synthesis, Molecular Docking and Anticancer Evaluation of New Arylazothiazoles
Sobhi M. Gomha et al.
CURRENT ORGANIC SYNTHESIS (2017)
Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors
Aliya Ibrar et al.
BIOORGANIC CHEMISTRY (2016)
An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma
Donna L. Nile et al.
BMC CANCER (2016)
The Cambridge Structural Database
Colin R. Groom et al.
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS (2016)
Synthesis and anticancer effects evaluation of 1-alkyl-3-(6-(2-methoxy-3-sulfonylaminopyridin-5-yl) benzo[d]thiazol-2-yl) urea as anticancer agents with low toxicity
Xiao-Xiao Xie et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Ethyl 2-((4-Chlorophenyl)amino)thiazole-4-carboxylate and Derivatives Are Potent Inducers of Oct3/4
Xinlai Cheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
The combined treatment with novel platinum(II) complex and anti-MUC1 increases apoptotic response in MDA-MB-231 breast cancer cells
Agnieszka Gornowicz et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells
Sachi Horibata et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
SHELXT - Integrated space-group and crystal-structure determination
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2015)
Crystal structure refinement with SHELXL
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY (2015)
Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism
C-M Hu et al.
ONCOGENE (2015)
Structural basis for the inhibition of poly(ADP-ribose) polymerases 1 and 2 by BMN 673, a potent inhibitor derived from dihydropyridophthalazinone
Mika Aoyagi-Scharber et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2014)
Dabrafenib: First Global Approval
Anita D. Ballantyne et al.
DRUGS (2013)
Structure-guided design of a selective BCL-XL inhibitor
Guillaume Lessene et al.
NATURE CHEMICAL BIOLOGY (2013)
Novel poly(ADP-ribose) polymerase-1 inhibitors
Derek Dunn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
WinGX and ORTEP for Windows: an update
Louis J. Farrugia
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2012)
Active Targeting Strategies for Anticancer Drug Nanocarriers
Livia Basile et al.
CURRENT DRUG DELIVERY (2012)
Dasatinib A Review of its Use in the Treatment of Chronic Myeloid Leukaemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia
Paul L. McCormack et al.
DRUGS (2011)
4-Pyridylanilinothiazoles That Selectively Target von Hippel-Lindau Deficient Renal Cell Carcinoma Cells by Inducing Autophagic Cell Death
Michael P. Hay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist
Gerald J. Prud'homme et al.
PLOS ONE (2010)
Structure validation in chemical crystallography
Anthony L. Spek
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2009)
Pharmacokinetics of Biotech Drugs: Peptides, Proteins and Monoclonal Antibodies
Jiunn H. Lin
CURRENT DRUG METABOLISM (2009)
OLEX2: a complete structure solution, refinement and analysis program
Oleg V. Dolomanov et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2009)
Design, Synthesis, and Cytoprotective Effect of 2-Aminothiazole Analogues as Potent Poly(ADP-Ribose) Polymerase-1 Inhibitors
Wen-Ting Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
A novel and simple method of screening compounds for interaction with DNA: A validation study
Adel Garas et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2009)
Molecular Docking Algorithms
Raquel Dias et al.
CURRENT DRUG TARGETS (2008)
Synthesis and anticonvulsant activity of some novel 3-aryl amino/amino-4-aryl-5-imino-Δ2-1,2,4-thiadiazoline
Arun Gupta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
An alternative method for the evaluation of docking performance: RSR vs RMSD
Dilmurat Yusuf et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
A high-throughput soft agar assay for identification of anticancer compound
Steven N. Anderson et al.
JOURNAL OF BIOMOLECULAR SCREENING (2007)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]-pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems
Sherif A. F. Rostom
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
O6-(4-bromothenyl)guanine reverses temozolomide resistance in human breast tumour MCF-7 cells and xenografts
M Clemons et al.
BRITISH JOURNAL OF CANCER (2005)
Protein-protein interactions and cancer: small molecules going in for the kill
M Arkin
CURRENT OPINION IN CHEMICAL BIOLOGY (2005)
Monoclonal antibodies, small molecules, and Vaccines in the treatment of breast cancer
FJ Esteva
ONCOLOGIST (2004)
Share Paper
